Skip to content

D&A at other companies

Spok Holdings logo
Spok HoldingsSPOK
$992K+15.5%
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
$8.33M-2.4%
National Research Corporation logo
National Research CorporationNRC
$2.17M+13.8%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$21.56M-10.4%
Cognizant logo
CognizantCTSH
$141M+3.7%
Claritev Corporation logo
Claritev CorporationCTEV
$85.91M-0.1%

Other financials

Income statement

See full
Revenue$70.8M-10.9%
Gross profit$35.5M-2.1%
Operating income-$106.5M-428%
Net income-$111.0M-368%
EPS (diluted)-$1.53-337%

Balance sheet

See full
Cash & equivalents$59.9M-82.5%
Total debt$170.6M-57.6%
Total equity$138.1M-63.3%
Total assets$412.2M-53.8%

Cash flow

See full
Operating cash flow$18.5M+6,511%
CapEx$338.0K-49.6%
Free cash flow$18.2M+4,760%

Valuation

See full
Market cap$147.05M-43.6%
Enterprise value$257.76M-32.7%
P/S0.5×-0.3×

Profitability

See full
Gross margin49.9%+4.7pp
Operating margin-81.7%-127pp
Net margin-87.7%-138pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-103%-135pp
Debt / equity1.2×+0.2×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Health Catalyst in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Health Catalyst's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Health Catalyst's D&A?
Health Catalyst (HCAT) reported D&A of $12.12M in Q1 2026.
How has Health Catalyst's D&A changed year-over-year?
Health Catalyst's D&A decreased by 1.7% year-over-year, from $12.32M to $12.12M.
What is the long-term trend for Health Catalyst's D&A?
Over 4 years (2021 to 2025), Health Catalyst's D&A has grown at a 7.7% compound annual growth rate (CAGR), from $37.53M to $50.5M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.